Response to Mammalian Target of Rapamycin–Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mut...

por Cuglievan, Branko, Subbiah, Vivek, Wang, Huamin, Morani, Ajaykumar, Meric-Bernstam, Funda, Holla, Vijaykumar, Herzog, Cynthia E.
Publicado 2018

Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2

por Sarkar, Sanila, Throckmorton, Whitney, Bingham, Racheal, Msaouel, Pavlos, Genovese, Giannicola, Slopis, John, Rao, Priya, Sadighi, Zsila, Herzog, Cynthia E.
Publicado 2023

Germline PTPRD Mutations in Ewing Sarcoma: Biologic and Clinical Implications

por Jiang, Yunyun, Janku, Filip, Subbiah, Vivek, Angelo, Laura S., Naing, Aung, Anderson, Peter M., Herzog, Cynthia E., Fu, Siqing, Benjamin, Robert S., Kurzrock, Razelle
Publicado 2013

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience

por Tarek, Nidale, Said, Rabih, Andersen, Clark R., Suki, Tina S., Foglesong, Jessica, Herzog, Cynthia E., Tannir, Nizar M., Patel, Shreyaskumar, Ratan, Ravin, Ludwig, Joseph A., Daw, Najat C.
Publicado 2020

Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials

por Livingston, J. Andrew, Hess, Kenneth R., Naing, Aung, Hong, David S., Patel, Shreyaskumar, Benjamin, Robert S., Ludwig, Joseph A., Conley, Anthony, Herzog, Cynthia E., Anderson, Pete, Meric-Bernstam, Funda, Kurzrock, Razelle, Subbiah, Vivek
Publicado 2016

Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas

por Dao, Long, Ragoonanan, Dristhi, Batth, Izhar, Satelli, Arun, Foglesong, Jessica, Wang, Jian, Zaky, Wafik, Gill, Jonathan B., Liu, Diane, Albert, Aisha, Gordon, Nancy, Huh, Winston, Harrison, Douglas, Herzog, Cynthia, Kleinerman, Eugenie, Gorlick, Richard, Daw, Najat, Li, Shulin
Publicado 2021

Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: The university of Texas MD And...

por Corrales-Medina, Fernando F., Herzog, Cynthia, Hess, Kenneth, Egas-Bejar, Daniela, Hong, David S., Falchook, Gerald, Anderson, Pete, Nunez, Cesar, Huh, Winston W., Naing, Aung, Tsimberidou, Apostolia M., Wheler, Jennifer, Paul, Sarina Piha, Janku, Filip, Kleinerman, Eugenie S., Kurzrock, Razelle, Subbiah, Vivek
Publicado 2014

Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors

por Dembla, Vikas, Groisberg, Roman, Hess, Ken, Fu, Siqing, Wheler, Jennifer, Hong, David S., Janku, Filip, Zinner, Ralph, Piha-Paul, Sarina Anne, Ravi, Vinod, Benjamin, Robert S., Patel, Shreyaskumar, Somaiah, Neeta, Herzog, Cynthia E., Karp, Daniel D., Roszik, Jason, Meric-Bernstam, Funda, Subbiah, Vivek
Publicado 2017

Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies

por Subbiah, Vivek, Hess, Kenneth R., Khawaja, Muhammad Rizwan, Wagner, Michael J., Tang, Chad, Naing, Aung, Fu, Siqing, Janku, Filip, Piha-Paul, Sarina, Tsimberidou, Apostolia M., Herzog, Cynthia E., Ludwig, Joseph A., Patel, Shreyaskumar, Ravi, Vinod, Benjamin, Robert S., Meric-Bernstam, Funda, Hong, David S.
Publicado 2016

A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma

por Anderson, Peter M., Bielack, Stefan S., Gorlick, Richard G., Skubitz, Keith, Daw, Najat C., Herzog, Cynthia E., Monge, Odd R., Lassaletta, Alvaro, Boldrini, Erica, Pápai, Zsuzanna, Rubino, Joseph, Pathiraja, Kumudu, Hille, Darcy A., Ayers, Mark, Yao, Siu‐Long, Nebozhyn, Michael, Lu, Brian, Mauro, David
Publicado 2016

Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas

por Groisberg, Roman, Hong, David S., Holla, Vijaykumar, Janku, Filip, Piha-Paul, Sarina, Ravi, Vinod, Benjamin, Robert, Patel, Shreyas Kumar, Somaiah, Neeta, Conley, Anthony, Ali, Siraj M., Schrock, Alexa B., Ross, Jeffrey S., Stephens, Philip J., Miller, Vincent A., Sen, Shiraj, Herzog, Cynthia, Meric-Bernstam, Funda, Subbiah, Vivek
Publicado 2017

Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

por Moyers, Justin T., Pestana, Roberto Carmagnani, Roszik, Jason, Hong, David S., Naing, Aung, Fu, Siqing, Piha-Paul, Sarina, Yap, Timothy A., Karp, Daniel, Rodon, Jordi, Livingston, Andy, Zarzour, Maria Alejandra, Ravi, Vinod, Patel, Shreyaskumar, Benjamin, Robert S., Ludwig, Joseph, Herzog, Cynthia, Ratan, Ravin, Somaiah, Neeta, Conley, Anthony, Gorlick, Richard, Meric-Bernstam, Funda, Subbiah, Vivek
Publicado 2023

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)

por Carmagnani Pestana, Roberto, Moyers, Justin T., Roszik, Jason, Sen, Shiraj, Hong, David S., Naing, Aung, Herzog, Cynthia E., Fu, Siqing, Piha-Paul, Sarina A., Rodon, Jordi, Yap, Timothy A., Karp, Daniel D., Tsimberidou, Apostolia M., Pant, Shubham, Zarzour, Maria A., Ratan, Ravin, Ravi, Vinod, Benjamin, Robert S., Lazar, Alexander J., Wang, Wei-Lien, Daw, Najat, Gill, Jonathan B., Harrison, Douglas J., Lewis, Valerae O., Roland, Christina L., Patel, Shreyaskumar R., Livingston, J. Andrew, Somaiah, Neeta, Ludwig, Joseph A., Conley, Anthony P., Hamerschlak, Nelson, Gorlick, Richard, Meric-Bernstam, Funda, Subbiah, Vivek
Publicado 2023